ReP USP - Resultado da busca

Artigo de periodico
West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery (2025)
Kocabiyik, Deren Zehra ; Álvarez, Lizdany Flórez ; Durigon, Edison Luiz ; Wrenger, Carsten
Fonte: Frontiers in Cellular and Infection Microbiology. Unidade: ICB
Assuntos: MICROBIOLOGIA, PARASITOLOGIA, VACINAS VIRAIS, ARBOVÍRUS, INFECÇÕES POR ARBOVIRUS, ANTIVIRAIS, DOENÇAS TRANSMISSÍVEIS, PROTEÍNAS, FLAVIVIRUS, REPLICAÇÃO VIRAL, CULEX, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOCABIYIK, Deren Zehra et al. West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery. Frontiers in Cellular and Infection Microbiology, v. 15, p. 9 , 2025Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2025.1568031. Acesso em: 08 out. 2025.
APA
Kocabiyik, D. Z., Álvarez, L. F., Durigon, E. L., & Wrenger, C. (2025). West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery. Frontiers in Cellular and Infection Microbiology, 15, 9 . doi:10.3389/fcimb.2025.1568031
NLM
Kocabiyik DZ, Álvarez LF, Durigon EL, Wrenger C. West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery [Internet]. Frontiers in Cellular and Infection Microbiology. 2025 ; 15 9 .[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fcimb.2025.1568031
Vancouver
Kocabiyik DZ, Álvarez LF, Durigon EL, Wrenger C. West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery [Internet]. Frontiers in Cellular and Infection Microbiology. 2025 ; 15 9 .[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fcimb.2025.1568031
Artigo de periodico
Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection (2025)
Santos, Yasmin da Silva ; Pagni, Roberta Liberato ; Gamon, Thaís Helena Martins; Azevedo, Marcela Santiago Pacheco de ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Luvizotto, Maria Cecília Rui; Ackerman, Hans Christian; Marinho, Claudio Romero Farias ; Carvalho, Leonardo José de Moura ; Epiphanio, Sabrina
Fonte: International Journal of Molecular Sciences. Unidades: ICB, FCF
Assuntos: COVID-19, CAMUNDONGOS, ANTAGONISMO DE DROGAS, ANGIOTENSINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin da Silva et al. Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection. International Journal of Molecular Sciences, v. 26, p. 1-18 art.7663, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/ijms26167663. Acesso em: 08 out. 2025.
APA
Santos, Y. da S., Pagni, R. L., Gamon, T. H. M., Azevedo, M. S. P. de, Darido, M. L. G., Oliveira, D. B. L. de, et al. (2025). Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection. International Journal of Molecular Sciences, 26, 1-18 art.7663. doi:10.3390/ijms26167663
NLM
Santos Y da S, Pagni RL, Gamon THM, Azevedo MSP de, Darido MLG, Oliveira DBL de, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF, Carvalho LJ de M, Epiphanio S. Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-18 art.7663.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3390/ijms26167663
Vancouver
Santos Y da S, Pagni RL, Gamon THM, Azevedo MSP de, Darido MLG, Oliveira DBL de, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF, Carvalho LJ de M, Epiphanio S. Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-18 art.7663.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.3390/ijms26167663
Artigo de periodico
P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity (2025)
Gomes, Vinicius de Morais ; Santos, Deivid Martins ; Macedo-da-Silva, Janaina ; Lázari, Lucas Cardoso ; Machado, Rafael Rahal Guaragna ; Santos, Ancély Ferreira dos ; Araujo, Danielle Bastos ; Coutinho, João Victor Paccini ; Arini, Gabriel Santos ; Souza, Edmarcia Elisa de ; Marques, Rodolfo Ferreira ; Boscardin, Silvia Beatriz ; Wrenger, Carsten ; Marinho, Claudio Romero Farias ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Labriola, Leticia ; Rosa-Fernandes, Livia ; Palmisano, Giuseppe
Fonte: Journal of Proteomics. Unidades: ICB, IQ
Assuntos: MICROBIOLOGIA, PARASITOLOGIA, VARIAÇÃO GENÉTICA, PROTEÔMICA, COVID-19, INFECÇÕES POR CORONAVIRUS, RETÍCULO ENDOPLASMÁTICO, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Vinicius de Morais et al. P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity. Journal of Proteomics, v. 315, p. 17 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.jprot.2025.105397. Acesso em: 08 out. 2025.
APA
Gomes, V. de M., Santos, D. M., Macedo-da-Silva, J., Lázari, L. C., Machado, R. R. G., Santos, A. F. dos, et al. (2025). P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity. Journal of Proteomics, 315, 17 . doi:10.1016/j.jprot.2025.105397
NLM
Gomes V de M, Santos DM, Macedo-da-Silva J, Lázari LC, Machado RRG, Santos AF dos, Araujo DB, Coutinho JVP, Arini GS, Souza EE de, Marques RF, Boscardin SB, Wrenger C, Marinho CRF, Oliveira DBL de, Durigon EL, Labriola L, Rosa-Fernandes L, Palmisano G. P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity [Internet]. Journal of Proteomics. 2025 ; 315 17 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.jprot.2025.105397
Vancouver
Gomes V de M, Santos DM, Macedo-da-Silva J, Lázari LC, Machado RRG, Santos AF dos, Araujo DB, Coutinho JVP, Arini GS, Souza EE de, Marques RF, Boscardin SB, Wrenger C, Marinho CRF, Oliveira DBL de, Durigon EL, Labriola L, Rosa-Fernandes L, Palmisano G. P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity [Internet]. Journal of Proteomics. 2025 ; 315 17 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.jprot.2025.105397
Artigo de periodico
Potential new avian species as carriers of diverse Circoviruses (2025)
Garcia, Yasmin Luisa Neves Lemes ; Gomes, Ana Júlia Chaves ; Guerra Neto, Guilherme ; Ando, Natasha Fujii; Sanches Rodrigues, Camila; Cesario, Richard Alegria ; Domit, Camila ; Lima, Fábio Henrique; Araujo Junior, João Pessoa ; Silva, Bruna Lindolfo da ; Spilki, Fernando Rosado ; Gamon, Thaís Helena Martins ; Assis, Isabela Barbosa de ; Oliveira, Danielle Bruna Leal de ; Costa, Vivaldo Gomes da ; Calmon, Marilia de Freitas ; Rahal, Paula ; Thomazelli, Luciano Matsumiya ; Ferreira, Helena Lage ; Durigon, Edison Luiz
Fonte: Pathogens. Unidades: FZEA, ICB, Interunidades em Biotecnologia
Assuntos: MICROBIOLOGIA, CIRCOVIRUS, CIRCOVIRIDAE, INFECÇÕES POR VÍRUS DE DNA, REAÇÃO EM CADEIA POR POLIMERASE, FILOGENIA, AVES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Yasmin Luisa Neves Lemes et al. Potential new avian species as carriers of diverse Circoviruses. Pathogens, v. 14, n. 6, p. 12 , 2025Tradução . . Disponível em: https://doi.org/10.3390/pathogens14060540. Acesso em: 08 out. 2025.
APA
Garcia, Y. L. N. L., Gomes, A. J. C., Guerra Neto, G., Ando, N. F., Sanches Rodrigues, C., Cesario, R. A., et al. (2025). Potential new avian species as carriers of diverse Circoviruses. Pathogens, 14( 6), 12 . doi:10.3390/pathogens14060540
NLM
Garcia YLNL, Gomes AJC, Guerra Neto G, Ando NF, Sanches Rodrigues C, Cesario RA, Domit C, Lima FH, Araujo Junior JP, Silva BL da, Spilki FR, Gamon THM, Assis IB de, Oliveira DBL de, Costa VG da, Calmon M de F, Rahal P, Thomazelli LM, Ferreira HL, Durigon EL. Potential new avian species as carriers of diverse Circoviruses [Internet]. Pathogens. 2025 ; 14( 6): 12 .[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pathogens14060540
Vancouver
Garcia YLNL, Gomes AJC, Guerra Neto G, Ando NF, Sanches Rodrigues C, Cesario RA, Domit C, Lima FH, Araujo Junior JP, Silva BL da, Spilki FR, Gamon THM, Assis IB de, Oliveira DBL de, Costa VG da, Calmon M de F, Rahal P, Thomazelli LM, Ferreira HL, Durigon EL. Potential new avian species as carriers of diverse Circoviruses [Internet]. Pathogens. 2025 ; 14( 6): 12 .[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pathogens14060540
Artigo de periodico
Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses (2025)
Ho, Paulo Lee ; Medina-Armenteros, Yordanka ; Dati, Lívia Mendonça Munhoz ; Cajado-Carvalho, Daniela ; Silva, Christian Savio ; Campos, Pollyanna Fernandes ; Abreu, Patrícia Antonia Estima ; Castro, Júlia Tavares de ; Tonolli, Paulo Newton ; Fujimori, Mahyumi ; Rosa, Rhubia Silveira Martins ; Palameta, Soledad ; Miller, Michael Edward ; Sakiara, Vitor Anselmo ; Valadares, Fernanda de Lima ; Lauretti-Ferreira, Fabiana ; Holanda, Bianca Pereira Carvalho ; Macedo, Douglas Gonçalves de; Comone, Priscila; Fogaça, Natully de Souza Suffert; Bimbo, Alexandre; Moraes, Felipe Catanzaro De; Andrade, Stephane Tereza Queiroz de; Arns, Clarice Weis ; Kallas, Esper Georges ; Akamatsu, Milena Apetito ; Oliveira, Ricardo das Neves ; Ferreira, Helena Lage ; Durigon, Edison Luiz
Fonte: Vaccines. Unidades: FZEA, ICB
Assuntos: MICROBIOLOGIA, MODELOS ANIMAIS DE DOENÇAS, INFLUENZA, IMUNOGENICIDADE DA VACINA, VACINAS VIRAIS, ADJUVANTES IMUNOLÓGICOS, HIDROCARBONETOS, ANTÍGENOS DE VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HO, Paulo Lee et al. Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses. Vaccines, v. 13, n. 6, p. 21 , 2025Tradução . . Disponível em: https://doi.org/10.3390/vaccines13060620. Acesso em: 08 out. 2025.
APA
Ho, P. L., Medina-Armenteros, Y., Dati, L. M. M., Cajado-Carvalho, D., Silva, C. S., Campos, P. F., et al. (2025). Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses. Vaccines, 13( 6), 21 . doi:10.3390/vaccines13060620
NLM
Ho PL, Medina-Armenteros Y, Dati LMM, Cajado-Carvalho D, Silva CS, Campos PF, Abreu PAE, Castro JT de, Tonolli PN, Fujimori M, Rosa RSM, Palameta S, Miller ME, Sakiara VA, Valadares F de L, Lauretti-Ferreira F, Holanda BPC, Macedo DG de, Comone P, Fogaça N de SS, Bimbo A, Moraes FCD, Andrade STQ de, Arns CW, Kallas EG, Akamatsu MA, Oliveira R das N, Ferreira HL, Durigon EL. Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses [Internet]. Vaccines. 2025 ; 13( 6): 21 .[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/vaccines13060620
Vancouver
Ho PL, Medina-Armenteros Y, Dati LMM, Cajado-Carvalho D, Silva CS, Campos PF, Abreu PAE, Castro JT de, Tonolli PN, Fujimori M, Rosa RSM, Palameta S, Miller ME, Sakiara VA, Valadares F de L, Lauretti-Ferreira F, Holanda BPC, Macedo DG de, Comone P, Fogaça N de SS, Bimbo A, Moraes FCD, Andrade STQ de, Arns CW, Kallas EG, Akamatsu MA, Oliveira R das N, Ferreira HL, Durigon EL. Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses [Internet]. Vaccines. 2025 ; 13( 6): 21 .[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/vaccines13060620
Artigo de periodico
Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections (2025)
Santos, Ingrid Nayara Marcelino ; Alberto-Lei, Felipe ; Santos, Fernanda Fernandes ; Balera, Mariana Felix Cerqueira ; Kurihara, Mariana Neri ; Cunha, Carolina Coelho; Seriacopi, Lais Sales ; Durigon, Thomas Stravinskas ; Reis, Fernando Baldy dos ; Eisen, Ana Karolina Antunes ; Caleiro, Giovana Santos ; Klautau, Giselle Burlamaqui ; Salles, Mauro José ; Araujo, Jansen de ; Durigon, Edison Luiz
Fonte: Scientific Reports. Unidade: ICB
Assuntos: MICROBIOLOGIA, GENÉTICA BACTERIANA, STAPHYLOCOCCUS, INFECÇÕES ESTAFILOCÓCICAS, ANTIBIÓTICOS, BIOFILMES, GENOMAS, TESTES DE SENSIBILIDADE MICROBIANA, FILOGENIA, DOENÇAS MUSCULOSQUELÉTICAS, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Ingrid Nayara Marcelino et al. Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections. Scientific Reports, v. 15, n. 1, p. 13 , 2025Tradução . . Disponível em: https://doi.org/10.1038/s41598-025-09061-4. Acesso em: 08 out. 2025.
APA
Santos, I. N. M., Alberto-Lei, F., Santos, F. F., Balera, M. F. C., Kurihara, M. N., Cunha, C. C., et al. (2025). Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections. Scientific Reports, 15( 1), 13 . doi:10.1038/s41598-025-09061-4
NLM
Santos INM, Alberto-Lei F, Santos FF, Balera MFC, Kurihara MN, Cunha CC, Seriacopi LS, Durigon TS, Reis FB dos, Eisen AKA, Caleiro GS, Klautau GB, Salles MJ, Araujo J de, Durigon EL. Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections [Internet]. Scientific Reports. 2025 ; 15( 1): 13 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-025-09061-4
Vancouver
Santos INM, Alberto-Lei F, Santos FF, Balera MFC, Kurihara MN, Cunha CC, Seriacopi LS, Durigon TS, Reis FB dos, Eisen AKA, Caleiro GS, Klautau GB, Salles MJ, Araujo J de, Durigon EL. Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections [Internet]. Scientific Reports. 2025 ; 15( 1): 13 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-025-09061-4
Artigo de periodico
Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort (2025)
Segabinazi, Ethiene ; Tocantins, Fernando Ribeiro ; Glaser, Talita ; Maglio, Tamires Gomes ; Oliveira, Nathalia Carrijo ; Castanha, Andrelissa Gorete ; Russo, Fabiele Baldino ; Leite, Paulo Emílio Corrêa ; Brito, Anita ; Molina, Camila Vieira ; Paludo, Gabriela Prado ; Souza, Raquel de Oliveira ; Alves, Simone Ravena Maia ; Cunha, Marielton Passos ; Ulrich, Henning ; Durigon, Edison Luiz ; Braga, Patricia Cristina Baleeiro Beltrão ; Minoprio, Paola Marcella Camargo
Fonte: Brain Behavior and Immunity Health. Unidades: IB, IQ, ICB, Interunidades em Biotecnologia
Assuntos: NEUROLOGIA, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEGABINAZI, Ethiene et al. Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort. Brain Behavior and Immunity Health, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.bbih.2025.101115. Acesso em: 08 out. 2025.
APA
Segabinazi, E., Tocantins, F. R., Glaser, T., Maglio, T. G., Oliveira, N. C., Castanha, A. G., et al. (2025). Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort. Brain Behavior and Immunity Health. doi:10.1016/j.bbih.2025.101115
NLM
Segabinazi E, Tocantins FR, Glaser T, Maglio TG, Oliveira NC, Castanha AG, Russo FB, Leite PEC, Brito A, Molina CV, Paludo GP, Souza R de O, Alves SRM, Cunha MP, Ulrich H, Durigon EL, Braga PCBB, Minoprio PMC. Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort [Internet]. Brain Behavior and Immunity Health. 2025 ;[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.bbih.2025.101115
Vancouver
Segabinazi E, Tocantins FR, Glaser T, Maglio TG, Oliveira NC, Castanha AG, Russo FB, Leite PEC, Brito A, Molina CV, Paludo GP, Souza R de O, Alves SRM, Cunha MP, Ulrich H, Durigon EL, Braga PCBB, Minoprio PMC. Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort [Internet]. Brain Behavior and Immunity Health. 2025 ;[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.bbih.2025.101115
Artigo de periodico
Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023 (2024)
Araujo, Andreina de Carvalho ; Cho, Andrew Yong ; Silva, Laura Morais Nascimento ; Port, Dagoberto ; Demoliner, Meriane ; Gularte, Juliana Schons ; Filippi, Michell ; Pereira, Vyctoria Malayhka de Abreu Goes ; Fisch, Fabiane ; Palameta, Soledad ; Branco, Joaquim Olinto ; Arns, Clarice Weis ; Lee, Sun-Hak ; Spilki, Fernando Rosado ; Lee, Dong-Hun ; Ferreira, Helena Lage ; Araújo, Jansen de ; Durigon, Edison Luiz
Fonte: Microbiology Resource Announcements. Unidades: FZEA, ICB, FMVZ
Assuntos: MICROBIOLOGIA, SEQUENCIAMENTO GENÉTICO, GENOMAS, INFLUENZA, AVES SILVESTRES, INFECÇÕES POR ORTHOMYXOVIRIDAE, INFECÇÕES POR VÍRUS DE RNA, FILOGENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Andreina de Carvalho et al. Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023. Microbiology Resource Announcements, p. 5 , 2024Tradução . . Disponível em: https://doi.org/10.1128/mra.00158-24. Acesso em: 08 out. 2025.
APA
Araujo, A. de C., Cho, A. Y., Silva, L. M. N., Port, D., Demoliner, M., Gularte, J. S., et al. (2024). Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023. Microbiology Resource Announcements, 5 . doi:10.1128/mra.00158-24
NLM
Araujo A de C, Cho AY, Silva LMN, Port D, Demoliner M, Gularte JS, Filippi M, Pereira VM de AG, Fisch F, Palameta S, Branco JO, Arns CW, Lee S-H, Spilki FR, Lee D-H, Ferreira HL, Araújo J de, Durigon EL. Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023 [Internet]. Microbiology Resource Announcements. 2024 ; 5 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1128/mra.00158-24
Vancouver
Araujo A de C, Cho AY, Silva LMN, Port D, Demoliner M, Gularte JS, Filippi M, Pereira VM de AG, Fisch F, Palameta S, Branco JO, Arns CW, Lee S-H, Spilki FR, Lee D-H, Ferreira HL, Araújo J de, Durigon EL. Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023 [Internet]. Microbiology Resource Announcements. 2024 ; 5 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1128/mra.00158-24
Artigo de periodico
SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern (2024)
Hojo-Souza, Nathalia Satchiko ; Castro, Júlia T. de; Rivelli, Graziella Gomes ; Azevedo, Patrick Orestes de ; Oliveira, Emiliano Castro de ; Faustino, Lídia Paula ; Salazar, Natália; Bagno, Flávia Fonseca ; Carvalho, Alex F.; Rattis, Bruna Amanda da Cruz ; Lourenço, Karine Lima ; Gomes, Isabela P.; Assis, Bruna Rodrigues Dias; Piccin, Mariela Pires Cabral ; Fonseca, Flavio Guimarães da ; Souza, Renan Pedra de ; Goulart, Gisele Assis Castro ; Santiago, Helton da Costa ; Gazzinelli, Ricardo Tostes ; Silva, João Santana da ; Durigon, Edison Luiz
Fonte: Vaccine. Unidades: FMRP, ICB
Assuntos: MICROBIOLOGIA, CAMUNDONGOS, HAMSTERS, PROTEÍNAS RECOMBINANTES, COVID-19, VACINAS VIRAIS, IMUNOGENICIDADE DA VACINA, IMUNIDADE, ADJUVANTES IMUNOLÓGICOS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOJO-SOUZA, Nathalia Satchiko et al. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, v. 42, n. 26, p. 16 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2024.126394. Acesso em: 08 out. 2025.
APA
Hojo-Souza, N. S., Castro, J. T. de, Rivelli, G. G., Azevedo, P. O. de, Oliveira, E. C. de, Faustino, L. P., et al. (2024). SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, 42( 26), 16 . doi:10.1016/j.vaccine.2024.126394
NLM
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Vancouver
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Artigo de periodico
Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster (2024)
Machado, Rafael Rahal Guaragna ; Candido, Erika Donizette de Oliveira ; Aguiar, Andressa Simões ; Chalup, Vanessa Nascimento ; Sanches, Patricia Romão ; Dorlass, Erick Gustavo ; Amgarten, Deyvid Emanuel ; Pinho, João Renato Rebello ; Oliveira, Danielle Bruna Leal de
Fonte: Vaccines. Unidades: FM, ICB, Interunidades em Bioinformática
Assuntos: MICROBIOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, VACINAS VIRAIS, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, ANTICORPOS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Rafael Rahal Guaragna et al. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, v. 12, n. 2, 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12020144. Acesso em: 08 out. 2025.
APA
Machado, R. R. G., Candido, E. D. de O., Aguiar, A. S., Chalup, V. N., Sanches, P. R., Dorlass, E. G., et al. (2024). Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, 12( 2). doi:10.3390/vaccines12020144
NLM
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/vaccines12020144
Vancouver
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/vaccines12020144
Artigo de periodico
Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis (2024)
Araujo, Andreina de Carvalho ; Cho, Andrew Yong ; Silva, Laura Morais Nascimento ; Corrêa, Thaís Camilo ; Souza, Gabriela Cristini de; Macagnan, Eduardo ; Kolesnikvoas, Cristiane K. M.; Meurer, Rafael ; Vieira, Jenyffer Vierheller ; Lemos, Giulia Gaglianone ; Barreto, André Silva ; Dick, Jeferson Luis ; Groch. Karina Rejane ; Castilho, Pedro Volkmer de ; Amgarten, Deyvid Emanuel ; Malta, Fernanda de Mello ; Miller, Michael; Dorlass, Erick Gustavo ; Palameta, Soledad ; Lee, Sun-Hak ; Arns, Clarice Weis ; Pinho, João Renato Rebello ; Lee, Dong-Hun ; Ferreira, Helena Lage ; Durigon, Edison Luiz
Fonte: BMC Veterinary Research. Unidades: FM, FZEA, ICB, Interunidades em Bioinformática
Assuntos: MICROBIOLOGIA, ORTHOMYXOVIRIDAE, VÍRUS DE RNA, INFECÇÕES POR VÍRUS DE RNA, FILOGENIA, GENOMAS, SEQUENCIAMENTO GENÉTICO, LEÕES, MAMÍFEROS MARINHOS, VARIAÇÃO GENÉTICA, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Andreina de Carvalho et al. Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis. BMC Veterinary Research, v. 20, n. 1, p. 8 , 2024Tradução . . Disponível em: https://doi.org/10.1186/s12917-024-04137-1. Acesso em: 08 out. 2025.
APA
Araujo, A. de C., Cho, A. Y., Silva, L. M. N., Corrêa, T. C., Souza, G. C. de, Macagnan, E., et al. (2024). Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis. BMC Veterinary Research, 20( 1), 8 . doi:10.1186/s12917-024-04137-1
NLM
Araujo A de C, Cho AY, Silva LMN, Corrêa TC, Souza GC de, Macagnan E, Kolesnikvoas CKM, Meurer R, Vieira JV, Lemos GG, Barreto AS, Dick JL, Groch. Karina Rejane, Castilho PV de, Amgarten DE, Malta F de M, Miller M, Dorlass EG, Palameta S, Lee S-H, Arns CW, Pinho JRR, Lee D-H, Ferreira HL, Durigon EL. Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis [Internet]. BMC Veterinary Research. 2024 ; 20( 1): 8 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1186/s12917-024-04137-1
Vancouver
Araujo A de C, Cho AY, Silva LMN, Corrêa TC, Souza GC de, Macagnan E, Kolesnikvoas CKM, Meurer R, Vieira JV, Lemos GG, Barreto AS, Dick JL, Groch. Karina Rejane, Castilho PV de, Amgarten DE, Malta F de M, Miller M, Dorlass EG, Palameta S, Lee S-H, Arns CW, Pinho JRR, Lee D-H, Ferreira HL, Durigon EL. Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis [Internet]. BMC Veterinary Research. 2024 ; 20( 1): 8 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1186/s12917-024-04137-1
Artigo de periodico
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 (2024)
Santos, Yasmin Silva ; Gamon, Thaís Helena Martins ; Azevedo, Marcela Santiago Pacheco de ; Bielavsky, Mônica ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Souza, Edmarcia Elisa de ; Luvizotto, Maria Cecília Rui ; Ackerman, Hans Christian; Carvalho, Leonardo José de Moura ; Epiphanio, Sabrina ; Wrenger, Carsten ; Durigon, Edison Luiz ; Marinho, Claudio Romero Farias
Fonte: Frontiers in Pharmacology. Unidades: FCF, ICB, Interunidades em Biotecnologia
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, COVID-19, INIBIDORES DE ENZIMAS, DOENÇAS RESPIRATÓRIAS, ANGIOTENSINA II, SISTEMA RENINA-ANGIOTENSINA, ANTIVIRAIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin Silva et al. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, v. 15, 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1414406. Acesso em: 08 out. 2025.
APA
Santos, Y. S., Gamon, T. H. M., Azevedo, M. S. P. de, Bielavsky, M., Darido, M. L. G., Oliveira, D. B. L. de, et al. (2024). Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, 15. doi:10.3389/fphar.2024.1414406
NLM
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Vancouver
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Artigo de periodico
Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil (2024)
Pereira, Samuel Pessoa ; Machado, Rafael Rahal Guaragna ; Farias, Jéssica Pires ; Adreata-Santos, Robert ; Rodrigues-Jesus, Monica Josiane ; Fogaça, Mayanna Moreira Costa ; Souza, Milena Silva ; Martins, Eduardo Gimenes; Romano, Camila Malta ; Amorim, Jaime Henrique ; Durigon, Edison Luiz ; Ferreira, Luis Carlos de Souza
Fonte: Journal of Medical Virology. Unidade: ICB
Assuntos: MICROBIOLOGIA, VÍRUS DA DENGUE, VÍRUS DE RNA, FLAVIVIRUS, ZIKA VÍRUS, IMUNOGLOBULINAS, PROTEÍNAS RECOMBINANTES, ANTÍGENOS DE VÍRUS, ANTICORPOS, DENGUE, INFECÇÕES POR ARBOVIRUS, CAMUNDONGOS, ELISA EM ANIMAL, TESTES SOROLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Samuel Pessoa et al. Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil. Journal of Medical Virology, v. 96, n. 12, p. , 2024Tradução . . Disponível em: https://doi.org/10.1002/jmv.70100. Acesso em: 08 out. 2025.
APA
Pereira, S. P., Machado, R. R. G., Farias, J. P., Adreata-Santos, R., Rodrigues-Jesus, M. J., Fogaça, M. M. C., et al. (2024). Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil. Journal of Medical Virology, 96( 12), . doi:10.1002/jmv.70100
NLM
Pereira SP, Machado RRG, Farias JP, Adreata-Santos R, Rodrigues-Jesus MJ, Fogaça MMC, Souza MS, Martins EG, Romano CM, Amorim JH, Durigon EL, Ferreira LC de S. Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil [Internet]. Journal of Medical Virology. 2024 ; 96( 12): .[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/jmv.70100
Vancouver
Pereira SP, Machado RRG, Farias JP, Adreata-Santos R, Rodrigues-Jesus MJ, Fogaça MMC, Souza MS, Martins EG, Romano CM, Amorim JH, Durigon EL, Ferreira LC de S. Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil [Internet]. Journal of Medical Virology. 2024 ; 96( 12): .[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/jmv.70100
Artigo de periodico
Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica (2024)
Jana, Subrata; Dyna, Andre Luiz ; Pal, Saikat; Mukherjee, Shuvam ; Bissochi, Isabella Maria Tomaz ; Ogatta, Sueli Fumie Yamada ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Ray, Bimalendu ; Faccin-Galhardi, Ligia Carla ; Ray, Sayani ; Durigon, Edison Luiz
Fonte: Carbohydrate Polymers. Unidade: ICB
Assuntos: MICROBIOLOGIA, ANTIVIRAIS, SIMPLEXVÍRUS, POLISSACARÍDEOS, HERPESVIRIDAE, REPLICAÇÃO VIRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANA, Subrata et al. Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica. Carbohydrate Polymers, v. 337, p. 13 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.carbpol.2024.122157. Acesso em: 08 out. 2025.
APA
Jana, S., Dyna, A. L., Pal, S., Mukherjee, S., Bissochi, I. M. T., Ogatta, S. F. Y., et al. (2024). Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica. Carbohydrate Polymers, 337, 13 . doi:10.1016/j.carbpol.2024.122157
NLM
Jana S, Dyna AL, Pal S, Mukherjee S, Bissochi IMT, Ogatta SFY, Darido MLG, Oliveira DBL de, Ray B, Faccin-Galhardi LC, Ray S, Durigon EL. Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica [Internet]. Carbohydrate Polymers. 2024 ; 337 13 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.carbpol.2024.122157
Vancouver
Jana S, Dyna AL, Pal S, Mukherjee S, Bissochi IMT, Ogatta SFY, Darido MLG, Oliveira DBL de, Ray B, Faccin-Galhardi LC, Ray S, Durigon EL. Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica [Internet]. Carbohydrate Polymers. 2024 ; 337 13 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.carbpol.2024.122157
Artigo de periodico
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern (2023)
Azevedo, Patrick Orestes de ; Souza, Natália Satchiko Hojo ; Faustino, Lídia Paula ; Fumagalli, Marcílio Jorge ; Hirako, Isabella C. ; Oliveira, Emiliano R.; Figueiredo, Maria M. ; Carvalho, Alex F.; Doro, Daniel; Benevides, Luciana ; Fonseca, Flávio; Machado, Alexandre M.; Fernandes, Ana P.; Teixeira, Santuza R. ; Silva, João S.; Gazzinelli, Ricardo T, ; Durigon, Edison Luiz
Fonte: npj Vaccines. Unidade: ICB
Assuntos: MICROBIOLOGIA, COVID-19, REPLICAÇÃO VIRAL, VARIAÇÃO GENÉTICA, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, HAMSTERS, EPITOPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Patrick Orestes de et al. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern. npj Vaccines, v. 8, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41541-023-00616-y. Acesso em: 08 out. 2025.
APA
Azevedo, P. O. de, Souza, N. S. H., Faustino, L. P., Fumagalli, M. J., Hirako, I. C., Oliveira, E. R., et al. (2023). Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern. npj Vaccines, 8, 1-17. doi:10.1038/s41541-023-00616-y
NLM
Azevedo PO de, Souza NSH, Faustino LP, Fumagalli MJ, Hirako IC, Oliveira ER, Figueiredo MM, Carvalho AF, Doro D, Benevides L, Fonseca F, Machado AM, Fernandes AP, Teixeira SR, Silva JS, Gazzinelli RT, Durigon EL. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern [Internet]. npj Vaccines. 2023 ; 8 1-17.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41541-023-00616-y
Vancouver
Azevedo PO de, Souza NSH, Faustino LP, Fumagalli MJ, Hirako IC, Oliveira ER, Figueiredo MM, Carvalho AF, Doro D, Benevides L, Fonseca F, Machado AM, Fernandes AP, Teixeira SR, Silva JS, Gazzinelli RT, Durigon EL. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern [Internet]. npj Vaccines. 2023 ; 8 1-17.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41541-023-00616-y
Artigo de periodico
Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation (2023)
Celestino, Gabriela Gomes; Amarante, Marla Karine ; Vespero, Eliana Carolina ; Tavares, Eliandro Reis ; Yamauchi, Lucy Megumi ; Candido, Érika Donizetti ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Ogatta, Sueli Fumie Yamada
Fonte: Pathogens. Unidades: ICB, Interunidades em Biotecnologia
Assuntos: MICROBIOLOGIA, TROMBOSE, COVID-19, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, MANIFESTAÇÕES CUTÂNEAS, FERIMENTOS E LESÕES, GENOMAS, SEQUENCIAMENTO GENÉTICO, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CELESTINO, Gabriela Gomes et al. Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation. Pathogens, v. 12, n. 3, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.3390/pathogens12030438. Acesso em: 08 out. 2025.
APA
Celestino, G. G., Amarante, M. K., Vespero, E. C., Tavares, E. R., Yamauchi, L. M., Candido, É. D., et al. (2023). Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation. Pathogens, 12( 3), 1-11. doi:10.3390/pathogens12030438
NLM
Celestino GG, Amarante MK, Vespero EC, Tavares ER, Yamauchi LM, Candido ÉD, Oliveira DBL de, Durigon EL, Ogatta SFY. Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation [Internet]. Pathogens. 2023 ; 12( 3): 1-11.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pathogens12030438
Vancouver
Celestino GG, Amarante MK, Vespero EC, Tavares ER, Yamauchi LM, Candido ÉD, Oliveira DBL de, Durigon EL, Ogatta SFY. Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation [Internet]. Pathogens. 2023 ; 12( 3): 1-11.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pathogens12030438
Artigo de periodico
Protein Arginylation is regulated during SARS-CoV-2 infection (2023)
Silva, Janaina Macedo da ; Fernandes, Livia Rosa ; Gomes, Vinicius de Morais ; Santiago, Veronica Feijoli ; Santos, Deivid Martins ; Molnar Catarina Maria Stanischesk ; Barboza, Bruno Rafael ; Souza, Edmarcia Elisa de ; Marques, Rodolfo Ferreira ; Boscardin, Silvia Beatriz ; Durigon, Edison Luiz ; Marinho, Claudio Romero Farias ; Wrenger, Carsten ; Marie, Suely Kazue Nagahashi ; Palmisano, Giuseppe
Fonte: Viruses. Unidades: ICB, FM
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, ENZIMAS, METABOLISMO DE PROTEÍNA, COVID-19, PROTEÍNAS, LISOSSOMOS, MACRÓFAGOS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Janaina Macedo da et al. Protein Arginylation is regulated during SARS-CoV-2 infection. Viruses, v. 15, n. 2, p. 1-25, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15020290. Acesso em: 08 out. 2025.
APA
Silva, J. M. da, Fernandes, L. R., Gomes, V. de M., Santiago, V. F., Santos, D. M., Molnar Catarina Maria Stanischesk,, et al. (2023). Protein Arginylation is regulated during SARS-CoV-2 infection. Viruses, 15( 2), 1-25. doi:10.3390/v15020290
NLM
Silva JM da, Fernandes LR, Gomes V de M, Santiago VF, Santos DM, Molnar Catarina Maria Stanischesk, Barboza BR, Souza EE de, Marques RF, Boscardin SB, Durigon EL, Marinho CRF, Wrenger C, Marie SKN, Palmisano G. Protein Arginylation is regulated during SARS-CoV-2 infection [Internet]. Viruses. 2023 ; 15( 2): 1-25.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/v15020290
Vancouver
Silva JM da, Fernandes LR, Gomes V de M, Santiago VF, Santos DM, Molnar Catarina Maria Stanischesk, Barboza BR, Souza EE de, Marques RF, Boscardin SB, Durigon EL, Marinho CRF, Wrenger C, Marie SKN, Palmisano G. Protein Arginylation is regulated during SARS-CoV-2 infection [Internet]. Viruses. 2023 ; 15( 2): 1-25.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/v15020290
Artigo de periodico
Potential outbreak by herpesvirus in equines: detection, clinical, and genetic analysis of equid gammaherpesvirus 2 (EHV-2) (2023)
Campos, Angélica Cristine Góes de Almeida ; Silva, Sofia Cicolo da ; Oliveira, Cairo Monteiro de ; Molina, Camila Vieira; Navas- Suárez, Pedro Enrique ; Santos, Thais Poltronieri dos ; Silveira, Vanessa Barbosa da ; Barbosa, Carla Meneguin ; Baccarin, Raquel Yvonne Arantes ; Góes, Luiz Gustavo Bentim ; Belli, Carla Bargi ; Durigon, Danielle Bruna Leal Oliveira ; Durigon, Edison Luiz
Fonte: Brazilian Journal of Microbiology. Unidades: Interunidades em Biotecnologia, FMVZ, ICB
Assuntos: MICROBIOLOGIA, HERPESVIRIDAE, EQUINOS, POTROS, ABORTO ANIMAL, ABORTO ESPONTÂNEO, RHODOCOCCUS, INFECÇÕES BACTERIANAS GRAM-POSITIVAS, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Angélica Cristine Góes de Almeida et al. Potential outbreak by herpesvirus in equines: detection, clinical, and genetic analysis of equid gammaherpesvirus 2 (EHV-2). Brazilian Journal of Microbiology, v. 54, p. 1137-1143, 2023Tradução . . Disponível em: https://doi.org/10.1007/s42770-022-00890-3. Acesso em: 08 out. 2025.
APA
Campos, A. C. G. de A., Silva, S. C. da, Oliveira, C. M. de, Molina, C. V., Navas- Suárez, P. E., Santos, T. P. dos, et al. (2023). Potential outbreak by herpesvirus in equines: detection, clinical, and genetic analysis of equid gammaherpesvirus 2 (EHV-2). Brazilian Journal of Microbiology, 54, 1137-1143. doi:10.1007/s42770-022-00890-3
NLM
Campos ACG de A, Silva SC da, Oliveira CM de, Molina CV, Navas- Suárez PE, Santos TP dos, Silveira VB da, Barbosa CM, Baccarin RYA, Góes LGB, Belli CB, Durigon DBLO, Durigon EL. Potential outbreak by herpesvirus in equines: detection, clinical, and genetic analysis of equid gammaherpesvirus 2 (EHV-2) [Internet]. Brazilian Journal of Microbiology. 2023 ; 54 1137-1143.[citado 2025 out. 08 ] Available from: https://doi.org/10.1007/s42770-022-00890-3
Vancouver
Campos ACG de A, Silva SC da, Oliveira CM de, Molina CV, Navas- Suárez PE, Santos TP dos, Silveira VB da, Barbosa CM, Baccarin RYA, Góes LGB, Belli CB, Durigon DBLO, Durigon EL. Potential outbreak by herpesvirus in equines: detection, clinical, and genetic analysis of equid gammaherpesvirus 2 (EHV-2) [Internet]. Brazilian Journal of Microbiology. 2023 ; 54 1137-1143.[citado 2025 out. 08 ] Available from: https://doi.org/10.1007/s42770-022-00890-3
Artigo de periodico
Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice (2023)
Santos, Yasmin da Silva ; Oliveira, Danielle Bruna Leal de ; Palmisano, Giuseppe ; Wrenger, Carsten ; Covas, Dimas Tadeu ; Curi, Rui ; Marinho, Claudio Romero Farias ; Durigon, Edison Luiz ; Epiphanio, Sabrina
Fonte: Viruses. Unidades: ICB, FMRP, FCF
Assuntos: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, VARIAÇÃO GENÉTICA, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, VIRULÊNCIA, CORONAVIRUS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin da Silva et al. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice. Viruses, v. 15, n. 4, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15040999. Acesso em: 08 out. 2025.
APA
Santos, Y. da S., Oliveira, D. B. L. de, Palmisano, G., Wrenger, C., Covas, D. T., Curi, R., et al. (2023). Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice. Viruses, 15( 4), 1-16. doi:10.3390/v15040999
NLM
Santos Y da S, Oliveira DBL de, Palmisano G, Wrenger C, Covas DT, Curi R, Marinho CRF, Durigon EL, Epiphanio S. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice [Internet]. Viruses. 2023 ; 15( 4): 1-16.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/v15040999
Vancouver
Santos Y da S, Oliveira DBL de, Palmisano G, Wrenger C, Covas DT, Curi R, Marinho CRF, Durigon EL, Epiphanio S. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice [Internet]. Viruses. 2023 ; 15( 4): 1-16.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/v15040999
Artigo de periodico
Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development (2023)
Almeida, Michelle Teixeira de; Barbosa, Ana Paula; Bomfim, Camila Gasque ; Vinces, Tania Churasacari ; Ceroni, Alexandre ; Durigon, Edison Luiz ; Guzzo, Cristiane Rodrigues
Fonte: Journal of Immunological Methods. Unidade: ICB
Assuntos: MICROBIOLOGIA, ANTICORPOS, EPITOPOS, LINFÓCITOS B, IMUNOGLOBULINAS, COVID-19, DIAGNÓSTICO CLÍNICO, PROTEÍNAS DA MEMBRANA, AMINOÁCIDOS, MODELOS ANIMAIS DE DOENÇAS, RATOS WISTAR, PROTEÍNAS RECOMBINANTES, IMUNOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Michelle Teixeira de et al. Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development. Journal of Immunological Methods, v. 522, p. 9 , 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jim.2023.113558. Acesso em: 08 out. 2025.
APA
Almeida, M. T. de, Barbosa, A. P., Bomfim, C. G., Vinces, T. C., Ceroni, A., Durigon, E. L., & Guzzo, C. R. (2023). Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development. Journal of Immunological Methods, 522, 9 . doi:10.1016/j.jim.2023.113558
NLM
Almeida MT de, Barbosa AP, Bomfim CG, Vinces TC, Ceroni A, Durigon EL, Guzzo CR. Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development [Internet]. Journal of Immunological Methods. 2023 ; 522 9 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.jim.2023.113558
Vancouver
Almeida MT de, Barbosa AP, Bomfim CG, Vinces TC, Ceroni A, Durigon EL, Guzzo CR. Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development [Internet]. Journal of Immunological Methods. 2023 ; 522 9 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.jim.2023.113558

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Assuntos

Título da fonte

Editora

País de publicação

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos